/PRNewswire/ HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announced that its AI-based qFibrosis®, qSteatosis®.
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts who underline the risk for comorbid conditions and cirrhosis.
Patients with nonalcoholic fatty liver disease are at risk for developing dementia and NAFLD plus cardiovascular disease or stroke hikes the risk even more, new research suggests.
Intercept Pharmaceuticals Inc will resubmit its application for approval of its therapy for a chronic liver disease to the FDA, two years after the regulator had declined to give the green light.